Basic Information
Immunotherapy is an exciting new treatment that harnesses the immune system to attack and kill cancer cells. One type of immunotherapy is oncolytic viruses, which are designed to specifically infect and destroy cancer cells. In addition to directly killing cancer cells, the most effective oncolytic viruses also stimulate the immune system to find and destroy cancer throughout the body. BeneVir’s oncolytic virus platform, based on T-Stealth TM technology, overcomes a major barrier to the clinical success of oncolytic viruses. This barrier is the human immune system, which can effectively kill both harmful viruses (such as influenza) and beneficial viruses (such as oncolytic viruses). BeneVir’s T-Stealth TM oncolytic viruses evade the immune system in order to directly destroy cancer cells by activating the immune system.